Cardia; James
Patent Applications and Registrations
Patent applications and USPTO patent grants for Cardia; James.The latest application filed is for "rna interference in dermal and fibrotic indications".
Company Profile
9.27.27
- Cardia; James - Franklin MA
Patent Activity
| Patent | Date |
|---|---|
| Methods for treating cancer using nucleic acids targeting MDM2 or MYCN Grant 11,279,934 - Byrne , et al. March 22, 2 | 2022-03-22 |
| Reduced size self-delivering RNAI compounds Grant 11,118,178 - Khvorova , et al. September 14, 2 | 2021-09-14 |
| Rna Interference In Dermal And Fibrotic Indications App 20210261968 - Khvorova; Anastasia ; et al. | 2021-08-26 |
| Reduced size self-delivering nucleic acid compounds targeting long non-coding RNA Grant 11,021,707 - Cardia , et al. June 1, 2 | 2021-06-01 |
| Reduced Size Self-delivering Rnai Compounds App 20210147849 - Khvorova; Anastasia ; et al. | 2021-05-20 |
| Nucleic acid molecules targeting superoxide dismutase 1 (SOD1) Grant 11,001,845 - Cardia , et al. May 11, 2 | 2021-05-11 |
| Rna Interference In Ocular Indications App 20210062195 - Libertine; Lyn ; et al. | 2021-03-04 |
| RNA interference in dermal and fibrotic indications Grant 10,913,948 - Khvorova , et al. February 9, 2 | 2021-02-09 |
| Reduced size self-delivering RNAI compounds Grant 10,876,119 - Khvorova , et al. December 29, 2 | 2020-12-29 |
| RNA interference in skin indications Grant 10,815,485 - Khvorova , et al. October 27, 2 | 2020-10-27 |
| Reduced size self-delivering RNAI compounds Grant 10,774,330 - Khvorova , et al. Sept | 2020-09-15 |
| RNA interference in ocular indications Grant 10,662,430 - Libertine , et al. | 2020-05-26 |
| Reduced Size Self-delivering Rnai Compounds App 20200002701 - Khvorova; Anastasia ; et al. | 2020-01-02 |
| Rna Interference In Ocular Indications App 20190233826 - Libertine; Lyn ; et al. | 2019-08-01 |
| Reduced Size Self-delivering Rnai Compounds App 20190161757 - Khvorova; Anastasia ; et al. | 2019-05-30 |
| Reduced size self-delivering RNAi compounds Grant 10,240,149 - Khvorova , et al. | 2019-03-26 |
| Reduced Size Self-delivering Nucleic Acid Compounds Targeting Long Non-coding Rna App 20190048341 - Cardia; James ; et al. | 2019-02-14 |
| RNA interference in ocular indications Grant 10,184,124 - Libertine , et al. Ja | 2019-01-22 |
| Rna Interference In Dermal And Fibrotic Indications App 20180371464 - Khvorova; Anastasia ; et al. | 2018-12-27 |
| Rna Interference In Skin Indications App 20180327748 - Khvorova; Anastasia ; et al. | 2018-11-15 |
| Reduced size self-delivering RNAi compounds Grant 10,041,073 - Khvorova , et al. August 7, 2 | 2018-08-07 |
| Nucleic Acid Molecules Targeting Superoxide Dismutase 1 (sod1) App 20180195072 - Cardia; James ; et al. | 2018-07-12 |
| RNA interference in dermal and fibrotic indications Grant 9,963,702 - Khvorova , et al. May 8, 2 | 2018-05-08 |
| RNA interference in skin indications Grant 9,938,530 - Khvorova , et al. April 10, 2 | 2018-04-10 |
| Rna Interference In Dermal And Fibrotic Indications App 20170067056 - Khvorova; Anastasia ; et al. | 2017-03-09 |
| Methods For Treating Cancer Using Nucleic Acids Targeting Mdm2 Or Mycn App 20170051288 - Byrne; Michael ; et al. | 2017-02-23 |
| Rna Interference In Skin Indications App 20170009239 - Khvorova; Anastasia ; et al. | 2017-01-12 |
| Methods For Treatment Of Wound Healing Utilizing Chemically Modified Oligonucleotides App 20160304875 - Cauwenbergh; Gerard ; et al. | 2016-10-20 |
| Reduced Size Self-delivering Rnai Compounds App 20160244765 - Khvorova; Anastasia ; et al. | 2016-08-25 |
| RNA interference in dermal and fibrotic indications Grant 9,340,786 - Khvorova , et al. May 17, 2 | 2016-05-17 |
| Reduced Size Self-delivering Rnai Compounds App 20160130578 - Khvorova; Anastasia ; et al. | 2016-05-12 |
| Rna Interference In Ocular Indications App 20160115482 - Libertine; Lyn ; et al. | 2016-04-28 |
| RNA interference in skin indications Grant 9,303,259 - Khvorova , et al. April 5, 2 | 2016-04-05 |
| Reduced size self-delivering RNAi compounds Grant 9,175,289 - Khvorova , et al. November 3, 2 | 2015-11-03 |
| RNA interference in ocular indications Grant 9,095,504 - Libertine , et al. August 4, 2 | 2015-08-04 |
| Reduced size self-delivering RNAi compounds Grant 9,080,171 - Khvorova , et al. July 14, 2 | 2015-07-14 |
| Reduced Size Self-delivering Rnai Compounds App 20140364482 - Khvorova; Anastasia ; et al. | 2014-12-11 |
| Rna Interference In Skin Indications App 20140315974 - KHVOROVA; ANASTASIA ; et al. | 2014-10-23 |
| Reduced size self-delivering RNAi compounds Grant 8,796,443 - Khvorova , et al. August 5, 2 | 2014-08-05 |
| Interference In Dermal And Fibrotic Indications App 20140113950 - Khvorova; Anastasia ; et al. | 2014-04-24 |
| RNA interference in skin indications Grant 8,664,189 - Khvorova , et al. March 4, 2 | 2014-03-04 |
| Rna Interference In Ocular Indications App 20130131142 - Libertine; Lyn ; et al. | 2013-05-23 |
| Reduced Size Self-delivering Rnai Compounds App 20130131141 - Khvorova; Anastasia ; et al. | 2013-05-23 |
| Reduced Size Self-delivering Rnai Compounds App 20120040459 - Khvorova; Anastasia ; et al. | 2012-02-16 |
| Reduced Size Self-delivering Rnai Compounds App 20110263680 - Khvorova; Anastasia ; et al. | 2011-10-27 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 